Lv58
1280 积分 2025-07-12 加入
Common ocular affections of childhood
1个月前
已完结
[Diaphragmatic hemiplegia]
1个月前
已关闭
Real-world analysis of teclistamab in 123 RRMM patients from Germany
1个月前
已完结
Defying the Odds: Successful Rescue with Teclistamab in a Case of Ultra- High-Risk Relapsed/Refractory Multiple Myeloma Transforming to Secondary Plasma Cell Leukemia Post-BCMA CAR T Failure
1个月前
已完结
Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies
1个月前
已完结
The Real‐World Safety and Efficacy of Bispecific T‐Cell Engager Therapy in Systemic AL Amyloidosis
3个月前
已完结
Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series
3个月前
已完结
Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis
3个月前
已完结
The Efficacy of Teclistamab in Multiple Myeloma Patients with Secondary Plasma Cell Leukemia
6个月前
已完结
Autonomic neuropathy, II: Specific peripheral neuropathies
7个月前
已完结
皖公网安备34019202002308